Viz HCM vs Withings Scan Monitor
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your hospital or health system requires an FDA-cleared AI tool for real-time, automated detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from 12-lead ECGs across your entire health system. This solution is ideal for rapidly alerting multidisciplinary care teams, streamlining cardiac care coordination, and significantly reducing the time to diagnosis and treatment for HCM patients within a clinical setting.
View Viz HCM →Choose Withings Scan Monitor if…
Choose Withings Scan Monitor if you are an individual seeking a consumer-friendly, FDA-cleared wearable solution for personal health monitoring, particularly for Atrial Fibrillation (AFib) detection via ECG, heart rate, and other vital metrics through smart scales and smartwatches. It is also well-suited for healthcare providers looking to implement remote patient monitoring programs, offering device-based data collection and cloud synchronization for ongoing patient oversight.
View Withings Scan Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz HCM | Withings Scan Monitor |
|---|---|---|
| Pricing | Unknown | Device purchase with optional subscription for enhanced features and clinical services. |
| Deployment | Unknown | Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Withings Scan MonitorWithings Scan Monitor (Tool B) emphasizes creating 'technology that people love' to integrate 'better health part of daily life,' suggesting a strong focus on intuitive, consumer-friendly design for a broad user base. While Viz HCM (Tool A) offers seamless integration into professional clinical workflows, Tool B's explicit commitment to user enjoyment and ease of personal use for daily monitoring gives it an edge in general usability.
Clinical Value
Viz HCMViz HCM (Tool A) provides significant clinical value by using AI-powered ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate care, which significantly reduces diagnosis time for a serious and often underdiagnosed condition. Its clinical validation with extensive real-world evidence and publications highlights its direct impact on critical patient outcomes. While Withings Scan Monitor (Tool B) offers valuable AFib detection and general health metrics, Viz HCM's specialized focus on a complex cardiac disease and its proven ability to streamline care pathways offer a higher degree of targeted clinical impact.
Pricing & Value
Withings Scan MonitorWithings Scan Monitor (Tool B) offers transparent pricing with a clear device purchase cost and an optional, affordable monthly subscription, making its value proposition easily understandable for individual users and smaller practices. Viz HCM (Tool A) operates on a subscription model for hospitals and health systems, with CMS reimbursement available, but requires direct vendor contact for enterprise pricing, making its overall cost and value less transparent for comparison. The clear, upfront pricing of Tool B provides a more accessible and quantifiable value proposition.
Enterprise Readiness
Viz HCMViz HCM (Tool A) is explicitly designed for enterprise deployment, integrating seamlessly into hospital IT systems, EHR, and PACS, and is offered on a subscription basis for hospitals and health systems. Its cloud-based platform and focus on streamlining clinical workflows demonstrate robust enterprise readiness. While Withings Scan Monitor (Tool B) is HIPAA compliant and can be used for professional remote patient monitoring, its primary deployment is device-based for individuals, making its enterprise integration capabilities less comprehensive compared to Tool A's system-level focus.
Innovation
Viz HCMViz HCM (Tool A) demonstrates significant innovation by leveraging AI for real-time ECG analysis to detect a complex and often missed condition like Hypertrophic Cardiomyopathy, coupled with automated direction of patients to specialists. This represents a substantial advancement in clinical decision support and care coordination for a specific, challenging disease. While Withings Scan Monitor (Tool B) innovatively integrates multiple advanced health metrics into consumer wearables, Viz HCM's focus on AI-driven diagnosis and workflow automation for a critical, systemic healthcare challenge stands out as a higher level of specialized healthcare AI innovation.
Support & Docs
TieNeither the provided structured facts nor general knowledge without specific web searches offer sufficient information regarding the support services or documentation available for either Viz HCM (Tool A) or Withings Scan Monitor (Tool B). Therefore, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | Withings Scan Monitor |
|---|---|---|
| Name | Viz HCM | Withings Scan Monitor |
| Company | Viz.ai | Withings |
| Primary Detection Focus | Hypertrophic Cardiomyopathy (HCM) | Atrial Fibrillation (AFib) |
| Key Feature 1 | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection | 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan) |
| Key Feature 2 | Real-time disease detection from electrocardiograms | Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch) |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and Withings Scan Monitor.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz HCM or Withings Scan Monitor
Backers
Who funded each tool's parent company.